HOUSTON, Sept. 4, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the Company has received approval for the trial

COLUMBUS, Ohio, Sept. 4, 2019 /PRNewswire/ -- We applaud the bold and courageous action of Michigan Governor Whitmer in recognizing flavored e-cigarettes as a health emergency and taking immediate steps to ban their sale in the state.  These enticingly flavored, sleek and heavily marketed devices are a clear and present danger to tee

DENVER, Sept. 4, 2019 /PRNewswire/ -- Eon, a Denver-based healthcare technology company, offers free Centers for Medicare & Medicaid Services (CMS) compliance audits to

NORFOLK, Va., Sept. 4, 2019 /PRNewswire/ -- Advancing Eyecare, a leading U.S. distributor of ophthalmic instruments and high-tech instrumentation to ophthalmologists and optometrists, today announced the acquisition of Ophthalmic Instruments, Inc. (OII), a leading distributor of quality ophthalmic instruments.Brad Staley

SUNNYVALE, Calif., Sept. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held in Chicago, IL. The presentations will commence at 3:00pm CT (4:00pm ET

DUBLIN, Sept. 4, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Novitium Pharma, LLC, a partner of Endo's subsidiary Endo Ventures Limited, received approval from the U.S. Food and Drug Administration for a room temperature stable, AB-rated, generic equivalent of Swedish Orphan Biovitrum's Orfadin® (nitisinone cap

MALVERN, Pa., Sept. 4, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Greenbrook TMS, a NeuroStar Advanced Therapy provider with 82 treatment centers ac

VANCOUVER, British Columbia, Sept. 4, 2019 /PRNewswire/ -- Natreve, the new premium wellness and supplement company, today announces its launch with the introduction of its line of real-food, highly a

BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock.Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase up to 4

SANTA CLARA, Calif., Sept. 4, 2019 /PRNewswire/ -- The class of monoclonal antibody (mAb) therapeutics has grown considerably in the past two decades and now makes up a significant portion of the biotherapeutics market. Pharmaceutical manufacturing operations continue to adjust to the increasing demand, particularly around the processes of harvest, clarification, an